Tumor Involvement of the Vitreous

2021 ◽  
pp. 1-8
Author(s):  
Benjamin A. King ◽  
Elaine M. Binkley ◽  
H. Culver Boldt
Keyword(s):  
Tumor Involvement

Can Preoperative Imaging Predict Tumor Involvement of the Anterior Clinoid in Clinoid Region Meningiomas?

2014 ◽  
Vol 75 (S 02) ◽  
Author(s):  
W. Copeland ◽  
J. Van Gompel ◽  
L. Eckel ◽  
K. Koeller ◽  
M. Link
Keyword(s):  
Preoperative Imaging ◽  
Tumor Involvement

The AJCC 8th edition no longer substages pT2 prostate cancer: Does extent of tumor involvement not matter?

2019 ◽  
Vol 18 (1) ◽  
pp. e216
Author(s):  
R.S. Pompe ◽  
F. Preisser ◽  
S. Leyh-Bannurah ◽  
P. Gild ◽  
G. Salomon ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Tumor Involvement ◽  
8Th Edition

scholarly journals The Role of Serum 5-HIAA as a Predictor of Progression and an Alternative to 24-h Urine 5-HIAA in Well-Differentiated Neuroendocrine Neoplasms

Biology ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 76
Author(s):  
Maria Wedin ◽  
Sagar Mehta ◽  
Jenny Angerås-Kraftling ◽  
Göran Wallin ◽  
Kosmas Daskalakis
Keyword(s):  
Liver Tumor ◽  
Disease Surveillance ◽  
Tumor Burden ◽  
Neuroendocrine Neoplasms ◽  
Mri Imaging ◽  
Exact Test ◽  
Recist 1.1 ◽  
Tumor Involvement ◽  
Well Differentiated ◽  
Disease Stages

Our aim was to investigate the clinical utility of serum 5HIAA for disease surveillance and diagnostic purposes in a cohort of patients with well-differentiated neuroendocrine neoplasms (WD-NENs). Forty-eight patients with WD-NENs and concurrent serum and urinary 5HIAA testing, as well as CT/MRI imaging, were included. Analysis of matching-pairs did not reveal any association between RECIST 1.1 responses and changes in serum 5HIAA levels (p = 0.673). In addition, no correlation was evident between RECIST 1.1 responses and >10%, >25% or >50% changes in serum 5HIAA levels (Fisher’s exact test p = 0.380, p > 0.999, and p > 0.999, respectively). The presence of liver metastases and extensive liver tumor involvement were associated with higher serum 5HIAA levels (p = 0.045 and p = 0.041, respectively). We also confirmed a strong linear correlation between the measurements of serum and urine 5HIAA (n = 24, r = 0.791, p < 0.0001). The concordance rate of serum and urinary 5HIAA positivity at standardized laboratory cut-offs was 75%. In patients with normal renal function tests, the concordance between the two methods was as high as 89%, and a sensitivity and specificity of 80% and 88.9%, respectively, was evident (Cohen’s kappa coefficient = 0.685). In conclusion, serum 5HIAA performs well compared to urinary testing for diagnostic purposes, mainly in advanced disease stages, and corresponds well to liver tumor burden. However, it is not adequate to predict tumor progression.

Eye Banking: Techniques for Eye Preservation in Selected Neoplasms Encroaching on the Globe

1993 ◽  
Vol 108 (6) ◽  
pp. 662-670 ◽  
Author(s):  
Vtto C. Quatela ◽  
Neal D. Futran ◽  
James R. Boynton
Keyword(s):  
Malignant Tumors ◽  
Eye Banking ◽  
Fibrous Sheath ◽  
Tumor Involvement ◽  
Preserve Function ◽  
Reconstructive Techniques ◽  
Improve Patient ◽  
Disease Free ◽  
Surgical Extirpation

Removal of the globe and associated structures has been advocated for tumors Invading the periorbital bone and periosteum, orbital fat, or extraocular muscles. In some patients with cancerous tumors encroaching on the globe, however, it may be possible to remove the tumor and save the eye. Tenon's fascia is a firm fibrous sheath surrounding the entire globe except the cornea. If the neoplasm spreads along fascial planes rather than through them, and If this layer remains free of tumor Involvement, preservation of the globe can be considered. Oculoplastic reconstructive techniques may limit exposure and diplopia, allowing the eye to be “banked” in vivo, and saved as a spare for the future. Six patients with malignant tumors encroaching on the globe have had definitive surgical extirpation with preservation of the eye. Three patients have had the globe uncovered successfully. Five of six patients remain disease-free, with followup from 6 months to 6 years. No globes have been removed. These techniques appear to be therapeutically sound, preserve function and appearance, and Improve patient morale. The indications and limitations of this approach to certain cases of periorbital cancer are discussed.

Continuous versus discontinuous tumor involvement: A dilemma in prostate biopsy quantitation

The Prostate ◽  
2018 ◽  
Vol 78 (15) ◽  
pp. 1166-1171 ◽  
Author(s):  
Caroline Bsirini ◽  
Alexandra M. Danakas ◽  
Hiroshi Miyamoto
Keyword(s):  
Prostate Biopsy ◽  
Tumor Involvement

Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry

1995 ◽  
Vol 12 (1) ◽  
pp. 14-22 ◽  
Author(s):  
Edneia Tani ◽  
Isabel Costa ◽  
Erik Svedmyr ◽  
Lambert Skoog
Keyword(s):  
Cerebrospinal Fluid ◽  
Metastatic Tumor ◽  
Tumor Involvement

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment

2017 ◽  
Vol 25 (2) ◽  
pp. 497-501 ◽  
Author(s):  
João Godinho ◽  
Mafalda Casa-Nova ◽  
Teresa Mesquita ◽  
Maria João Baptista ◽  
Francisco Araújo ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Clinical Findings ◽  
Neurological Dysfunction ◽  
Toxic Encephalopathy ◽  
Central Nervous System Toxicity ◽  
Cerebellar Dysfunction ◽  
Oxaliplatin Treatment ◽  
Tumor Involvement ◽  
The Central Nervous System

Introduction Capecitabine is a fluoropyrimidine commonly used in the treatment of colorectal cancer which may cause central nervous system toxicity, namely cerebellar dysfunction. Case report We describe a 77-year-old man undergoing adjuvant treatment of colon cancer with capecitabine and oxaliplatin who presented with acute cerebellar ataxia and encephalopathy that progressed to coma. Diagnosis of toxic encephalopathy was made after the exclusion of alternative causes of neurological dysfunction and complete resolution of clinical findings with permanent discontinuation of chemotherapy. Discussion When patients with cancer develop symptoms and signs of central nervous dysfunction, metabolic and infectious causes plus tumor involvement of central nervous system must be sought. However, chemotherapy may also cause toxicity to the central nervous system. Capecitabine is no exception, although cerebellar dysfunction is rarely reported. Conclusion Although rare, capecitabine-induced encephalopathy may be severe and physicians should be aware of this possible side effect.

The value of bone scintigraphy on the determination of the full extent of tumor involvement in jaw bones

2009 ◽  
Vol 8 (1) ◽  
pp. 42-45
Author(s):  
Jiawei Xie ◽  
Chao Ma ◽  
Guoming Wang ◽  
Shuyao Zuo ◽  
Ningyi Li ◽  
...  
Keyword(s):  
Bone Scintigraphy ◽  
Full Extent ◽  
Jaw Bones ◽  
Tumor Involvement

Radiologic and clinical outcomes with special reference to tumor involvement pattern after stent placement for malignant bronchial obstructions

2009 ◽  
Vol 50 (9) ◽  
pp. 1011-1018 ◽  
Author(s):  
Ji Hoon Shin ◽  
Ho-Young Song ◽  
Kyung-Rae Kim ◽  
Jin Hyoung Kim ◽  
Sang Wee Kim ◽  
...  
Keyword(s):  
Special Reference ◽  
Clinical Outcomes ◽  
Stent Placement ◽  
Tumor Involvement

Adult Granulosa Cell Tumor of the Ovary: A Clinico Pathologic Study of 35 Cases

1998 ◽  
Vol 84 (1) ◽  
pp. 60-64 ◽  
Author(s):  
Rosanna Fontanelli ◽  
Bernardina Stefanon ◽  
Francesco Raspagliesi ◽  
Rado Kenda ◽  
Gorana Tomasic ◽  
...  
Keyword(s):  
Granulosa Cell ◽  
Disease Free Survival ◽  
Granulosa Cell Tumor ◽  
Cell Tumor ◽  
Progression Rate ◽  
Free Survival ◽  
Tumor Involvement ◽  
Disease Free Survival Rate ◽  
Disease Free

Aims and background Adult granulosa cell tumor has a low malignant potential but requires an extensive follow-up of more than 5 years to accurately assess tumor activity. The aim of the present study was to evaluate the clinical characteristics, the treatment and the outcome of this rare ovarian tumor. Study design A retrospective review of 35 cases treated at primary onset of disease during a 23-year period from 1971 to 1993. Results The disease-free survival rate for stages IA-B-C at 5 and 10 years was 90% and 84%, respectively; for stages III-IV the 5-year freedom from progression rate was 16%. Conclusions The most important prognostic factor appears to be the extent of tumor involvement outside of the ovary.

Sign in / Sign up

Export Citation Format

Share Document